What are the common etiologies of pericardial effusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Common Etiologies of Pericardial Effusion

The etiology of pericardial effusion varies dramatically by geographic location and clinical setting: in developed countries, viral infections and idiopathic causes predominate, while tuberculosis remains the leading cause worldwide, particularly in endemic regions and among HIV-positive patients. 1

Geographic and Epidemiologic Considerations

The most critical factor determining etiology is your practice location and patient population:

  • In developed countries: Viruses are the most common infectious agents causing pericardial effusion 1
  • Globally and in developing countries: Tuberculosis (TB) is the most frequent cause, especially in TB-endemic areas 1
  • In sub-Saharan Africa: TB pericardial disease is often associated with HIV co-infection 1

Major Etiologic Categories

Infectious Causes

Viral etiologies are the predominant infectious cause in developed nations, though specific viral identification is rarely performed in uncomplicated cases 1. Coxsackie B virus can cause hemorrhagic pericardial effusion, though this is rare 2.

Bacterial infections including sepsis require bacterial cultures for diagnosis, particularly in purulent effusions 1. TB must be considered in endemic areas and immunocompromised patients 1.

Non-Infectious Causes (Common)

Autoimmune diseases account for a significant proportion of cases and include 1:

  • Systemic lupus erythematosus
  • Sjögren syndrome
  • Rheumatoid arthritis
  • Scleroderma
  • Systemic vasculitides (eosinophilic granulomatosis with polyangiitis, Behçet syndrome)
  • Sarcoidosis

Approximately 5-15% of pericarditis cases have an underlying autoimmune etiology, and pericardial involvement typically mirrors overall disease activity 3.

Neoplastic causes are common and critically important to identify 1:

  • Secondary metastatic tumors (common): Most frequently from lung cancer, breast cancer, and lymphoma 1
  • Primary tumors (rare): Pericardial mesothelioma 1
  • In patients with known malignancy, approximately two-thirds of pericardial effusions are actually due to non-malignant causes such as radiation-induced pericarditis or therapy-related effects 3
  • Neoplastic effusions most frequently result from bronchus carcinoma or breast cancer 1

Metabolic causes include 1:

  • Uremia: Occurs in approximately 5% of patients initiating dialysis, with higher incidence in the first three months 3
  • Hypothyroidism: Associated with pericardial effusion in 5-30% of cases, presenting with relative bradycardia, low QRS voltage on ECG, and elevated TSH 3
  • Myxedema (hypothyroid patients rarely progress to tamponade despite potentially large effusions) 3
  • Anorexia nervosa 1

Traumatic and iatrogenic causes are common and include 1:

  • Delayed-onset pericardial injury syndromes (common): Post-myocardial infarction syndrome, post-pericardiotomy syndrome, post-traumatic syndromes
  • Iatrogenic trauma: Following coronary percutaneous intervention, pacemaker lead insertion, radiofrequency ablation 1
  • Direct penetrating thoracic injury, esophageal perforation (rare) 1
  • Radiation injury 1

Other common causes 1:

  • Hypertension and chronic heart failure
  • Idiopathic pericardial effusion (most common in developed countries when no inflammatory signs present) 4, 5

Drug-Related Causes (Rare)

Multiple medications can cause pericardial effusion 1:

  • Lupus-like syndrome: Procainamide, hydralazine, methyldopa, isoniazid, phenytoin
  • Antineoplastic drugs: Doxorubicin, daunorubicin (often with associated cardiomyopathy)
  • Other agents: Amiodarone, methysergide, mesalazine, clozapine, minoxidil, anti-TNF agents

Clinical Patterns That Predict Etiology

Presence of acute inflammatory signs (chest pain, fever, pericardial friction rub) predicts acute idiopathic pericarditis regardless of effusion size or tamponade presence 5.

Severe effusion without inflammatory signs and without tamponade predicts chronic idiopathic pericardial effusion 5.

Tamponade without inflammatory signs predicts neoplastic pericardial effusion 5.

Serosanguinous or hemorrhagic fluid can occur in malignant, post-pericardiotomy, rheumatologic, traumatic, iatrogenic, idiopathic, and viral forms 1. The most common causes of hemorrhagic effusion are myocardial infarction, trauma, aortic dissection, or cardiac surgery 6.

Critical Diagnostic Considerations

Fluid cytology separates malignant from non-malignant effusions, which is essential for tumor patients after mediastinal radiotherapy 1. Higher tumor marker levels in pericardial fluid distinguish malignant from autoreactive effusions 1.

In dialysis patients, chronic effusions develop secondary to continuous volume overload, and uremic pericarditis can occur despite apparently adequate dialysis 3. Hemorrhagic effusion in uremic patients increases tamponade risk with anticoagulation 3.

Bacterial cultures are diagnostic in sepsis, TB, or HIV-positive patients 1. PCR for microbial agents in fluid and tissue allows definitive etiological diagnosis in many cases 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.